News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
‘Like Finding Gold in Trafalgar Square’: Gene Breakthrough

03/05/11

In a surprise finding, three new breast cancer genes have been discovered next to the oestrogen receptor gene, which has been intensively studied by scientists for decades
ICR Logo
Prostate Cancer Patients to Benefit from Drug Discovered at the ICR

28/04/11

A drug discovered at the ICR has today been approved in the US for use by men with metastatic prostate cancer.
ICR Logo
Genetics are Key to Age at Which Girls Start their Periods

13/04/11

Genetic makeup explains more than half of the variation between UK women’s ages at first period, according to a study of almost 26,000 UK women published today.
ICR Logo
First Patients To Receive New Cancer Drug AZD5363

12/04/11

An experimental drug the ICR helped discover has started Phase I safety testing in a range of cancer types.
ICR Logo
Blood Test Shows Potential to Predict Treatment Response

01/04/11

Scientists at the ICR have shown evidence that a blood test can quickly identify patients who are responding to a new type of personalised cancer treatment.
ICR Logo
New Radiotherapy Technique May Save More Healthy Breast Tissue

15/03/11

A new study will confirm whether an advanced radiotherapy technique that uses imaging of titanium clips implanted during surgery can reduce side-effects from breast cancer treatment.
ICR Logo
The ICR, Cancer Research Technology and Zobio BV Sign Deal to Develop Cancer Drugs

11/03/11

The three organisations are collaborating to discover and develop drugs to block a DNA repair target that may play a role in cancer cell survival.
ICR Logo
Gene Test to Predict Nerve Damage from Bone Cancer Treatment

01/03/11

Scientists have found a genetic test that predicts whether bone marrow cancer treatments including thalidomide are likely to give patients a debilitating side-effect.
ICR Logo
Two-pronged Approach Brings Hope For Bowel Cancer Treatment

01/03/11

Cancer Research UK-funded scientists have discovered that blocking two cell DNA repair routes at once could provide a completely new way to treat bowel cancer and potentially other cancers.
ICR Logo
Study Confirms Therapy Could Halt Breast Cancer Spread

22/02/11

ICR scientists have for the first time shown that blocking a key enzyme can stop breast cancer spreading to distant organs.
ICR Logo
The Art of Structural Biology: modelling the APC Complex

21/02/11

The molecular machine controlling cell growth Professor David Barford leads a team within the Section of Structural Biology that has recently published work in the prestigious scientific journal Nature* examining the structure of a protein complex known as the anaphase-promoting complex (APC/C).
ICR Logo
First National Data on Breast Cancers that Occur Between Screenings

16/02/11

The first UK-wide study into the rate of breast cancers diagnosed between scheduled screenings has been published today in the British Journal of Cancer.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.